| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |